November 25, 2007
Subject – Result analysis: Nexense “SleepAP” VS PSG (Embla A-10).
Attached please find summary reports of a sleep study conducted 20-May-07.
Subject description:
Female,
Age – 45,
Height -162cm,
Wight – 96kg,
BMI = 36.64.
The study was conducted in the patient’s home using A – 10 Embla PSG & “SleepAP” by Nexense
Simultaneously, the subject was reefed to the study due to – excessive daytime somnolence & snoring.
The PSG results show an RDI = 21 respiratory events per hour.
EEG shows no indication of abnormal motor activity.
Sleep Stages – ~ normal- with REM time slightly shorter then normal for her age.
The SleepAP system detected – a total of 24.3 respiratory events per hour for the same duration.
I find The difference in results low & is probably due to definitions of event analysis that is not standard – in terms of sensitivity I find this system interesting & shows promise – need to conduct several studies more in order to validate the findings.
Conclusion: The SleepAP system shows promise & when validated could be used as a great screening tool for OSA.
Respectfully,
Dr, Avi Blonder
Maarag Ltd.
Israel.
23 November 2007
Nexense Ltd. Apnea. SleePure Plus system.
The apnea events decrease by 20% in 10 days of use the Nexense SleePure Plus with the FeedBack device.
The nights 1-2 and 12-13, November, 2007 were monitored without the Feedback device.
22 November 2007
07 November 2007
Nexense Ltd. Anti-snoring. Anti-apnea.
Introducing NexaverTM SleePure
The Revolutionary Anti-Snoring Solution
“Because Quality of Life Begins with a Good Night’s Sleep “
Nexense Ltd., a world leader in sensor technology, is proud to introduce its Revolutionary Anti-Snoring Solution, NexaverTM SleePure.
It has been well documented in recent years that sleep-related breathing disorders, especially snoring, have been linked to several types of heart disease, including an increased risk of heart attacks, high blood-pressure, stroke and other cardiovascular events.
“Loud and frequent snoring can be more than a nuisance to your partner. This nighttime annoyance may indicate a serious health condition and it can disrupt your household and strain your relationship. “
MayoClinic.com
Snoring is a wide spread sleep disturbance effecting the whole spectrum of the adult population.
• 30% of those over age 30 snore, rising to 40% in middle-age.
(Source: British Medical Journal, 1997)
• Two-thirds of partnered adults say their partner snores, while 6 out of 10 of all adults say they snore.
(Source: National Sleep Foundation, 2005)
• Male: Female ratio= 2:1 with the gap closing after menopause.
(Source: Vancouver sleep and breathing center)
What is also widely known is the relationship between habitual snoring and various types of Sleep Apnea.
• Sleep Apnea may be present in 20-40% of the adult population that experience snoring. (Source: National Sleep Foundation)
The devastating consequences of a person suffering from Sleep Apnea have been well documented in medical studies.
• An individual with untreated apnea (OSA) is up to 4 times more likely to have a stroke and 3 times more likely to have a heart disease. (Source: National Sleep Foundation)
• People suffering from sleep apnea are 6 times more likely to be involved in a car crash than those without sleep disorders. (Source: New England Journal of Medicine, 1999)
Nexense Ltd., utilizing its quantum leap innovative sensor technology, has developed a proven solution to the snoring problem, the Nexaver™ SleePure System.
The Nexaver™ SleePure System monitors sleep behavior and outputs a gentle biofeedback upon snore detection. The System allows users to learn how to enjoy free air flow to reduce or cease snoring. The Nexaver™ SleePure improves sleep quality and potentially reduces this risk of long-term heart-related conditions.
The Nexaver™ SleePure System has been successfully tested and has shown excellent results in significantly reducing the amount of snores as well as reducing the intensity of the less frequent sleep disturbances.
To date, the effectiveness of currently available anti- snoring products have either been virtually ineffective, extremely costly or terribly uncomfortable.
The enormous, untapped, sleep disturbance market requires a more effective, more economical and more user friendly solution. The market deserves The Nexaver™ SleePure System.
The Revolutionary Anti-Snoring Solution
“Because Quality of Life Begins with a Good Night’s Sleep “
Nexense Ltd., a world leader in sensor technology, is proud to introduce its Revolutionary Anti-Snoring Solution, NexaverTM SleePure.
It has been well documented in recent years that sleep-related breathing disorders, especially snoring, have been linked to several types of heart disease, including an increased risk of heart attacks, high blood-pressure, stroke and other cardiovascular events.
“Loud and frequent snoring can be more than a nuisance to your partner. This nighttime annoyance may indicate a serious health condition and it can disrupt your household and strain your relationship. “
MayoClinic.com
Snoring is a wide spread sleep disturbance effecting the whole spectrum of the adult population.
• 30% of those over age 30 snore, rising to 40% in middle-age.
(Source: British Medical Journal, 1997)
• Two-thirds of partnered adults say their partner snores, while 6 out of 10 of all adults say they snore.
(Source: National Sleep Foundation, 2005)
• Male: Female ratio= 2:1 with the gap closing after menopause.
(Source: Vancouver sleep and breathing center)
What is also widely known is the relationship between habitual snoring and various types of Sleep Apnea.
• Sleep Apnea may be present in 20-40% of the adult population that experience snoring. (Source: National Sleep Foundation)
The devastating consequences of a person suffering from Sleep Apnea have been well documented in medical studies.
• An individual with untreated apnea (OSA) is up to 4 times more likely to have a stroke and 3 times more likely to have a heart disease. (Source: National Sleep Foundation)
• People suffering from sleep apnea are 6 times more likely to be involved in a car crash than those without sleep disorders. (Source: New England Journal of Medicine, 1999)
Nexense Ltd., utilizing its quantum leap innovative sensor technology, has developed a proven solution to the snoring problem, the Nexaver™ SleePure System.
The Nexaver™ SleePure System monitors sleep behavior and outputs a gentle biofeedback upon snore detection. The System allows users to learn how to enjoy free air flow to reduce or cease snoring. The Nexaver™ SleePure improves sleep quality and potentially reduces this risk of long-term heart-related conditions.
The Nexaver™ SleePure System has been successfully tested and has shown excellent results in significantly reducing the amount of snores as well as reducing the intensity of the less frequent sleep disturbances.
To date, the effectiveness of currently available anti- snoring products have either been virtually ineffective, extremely costly or terribly uncomfortable.
The enormous, untapped, sleep disturbance market requires a more effective, more economical and more user friendly solution. The market deserves The Nexaver™ SleePure System.
02 November 2007
Subscribe to:
Posts (Atom)